401 related articles for article (PubMed ID: 16987064)
1. Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes.
Ohno S; Moriya O; Yoshimoto T; Hayashi H; Akatsuka T; Matsui M
Viral Immunol; 2006; 19(3):458-67. PubMed ID: 16987064
[TBL] [Abstract][Full Text] [Related]
2. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
[TBL] [Abstract][Full Text] [Related]
3. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
[TBL] [Abstract][Full Text] [Related]
5. Prediction and identification-based prediction of Chinese hepatitis C viral-specific cytotoxic T lymphocyte epitopes.
Duan L; Lei P; Yumei X; Xiaoping X; Futao Z; Li M; Xin W; Jiuping W; Xuefan B; Zhansheng J
J Med Virol; 2011 Aug; 83(8):1315-20. PubMed ID: 21618548
[TBL] [Abstract][Full Text] [Related]
6. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
[TBL] [Abstract][Full Text] [Related]
7. In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus.
Malmassari S; Lone YC; Zhang M; Transy C; Michel ML
Microbes Infect; 2005 Apr; 7(4):626-34. PubMed ID: 15820153
[TBL] [Abstract][Full Text] [Related]
8. New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
Wang Y; Takao Y; Harada M; Yutani S; Ide T; Sata M; Itoh K; Yamada A
Microbiol Immunol; 2006; 50(11):857-65. PubMed ID: 17116980
[TBL] [Abstract][Full Text] [Related]
9. Identification of Mycobacterium tuberculosis CTL epitopes restricted by HLA-A*0201 in HHD mice.
Rafiei A; Kiutade Y
Iran Biomed J; 2007 Jan; 11(1):23-31. PubMed ID: 18051701
[TBL] [Abstract][Full Text] [Related]
10. Optimized vaccination regimen linked to exhaustive screening approaches identifies 2 novel HLA-B7 restricted epitopes within hepatitis C virus NS3 protein.
Martin P; Parroche P; Pajot A; Chatel L; Barreto C; Touat L; Dubois V; Rohrlich PS; Bain C; Trépo C; Negro F; Inchauspé G; Fournillier A
Microbes Infect; 2006 Aug; 8(9-10):2432-41. PubMed ID: 16859951
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
[TBL] [Abstract][Full Text] [Related]
12. Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes.
Alexander J; Oseroff C; Sidney J; Sette A
Hum Immunol; 2003 Feb; 64(2):211-23. PubMed ID: 12559623
[TBL] [Abstract][Full Text] [Related]
13. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
[TBL] [Abstract][Full Text] [Related]
14. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.
Wentworth PA; Sette A; Celis E; Sidney J; Southwood S; Crimi C; Stitely S; Keogh E; Wong NC; Livingston B; Alazard D; Vitiello A; Grey HM; Chisari FV; Chesnut RW; Fikes J
Int Immunol; 1996 May; 8(5):651-9. PubMed ID: 8671652
[TBL] [Abstract][Full Text] [Related]
15. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
[TBL] [Abstract][Full Text] [Related]
16. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
Wang Y; Takao Y; Harada M; Komatsu N; Ono T; Sata M; Itoh K; Yamada A
Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
[TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
[TBL] [Abstract][Full Text] [Related]
19. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
Tsuchida T; Parker KC; Turner RV; McFarland HF; Coligan JE; Biddison WE
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10859-63. PubMed ID: 7526383
[TBL] [Abstract][Full Text] [Related]
20. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
